以重点监控药品管理促进合理用药水平提升

通过开展以“合理用药”为核心的重点监控药品管理,促进合理用药水平提升。采取事后处方点评及处方前置审核,建立和完善重点监控药品管理方案,对不合理用药进行拦截、宣教、绩效处罚、限量采购、约谈等,实现了重点监控药品规范化管理。实践后,不合理医嘱减少,处方点评合格率提升,辅助用药种类减少。认为建立重点监控药品管理的相关制度及流程,对提升合理用药水平有一定促进作用。     

提质增量,卓越发展:《国家科学评论》办刊实践与进展

【目的】 介绍《国家科学评论》(National Science Review,NSR)的办刊实践,以期促进我国英文科技期刊办刊经验的交流。【方法】 以NSR为研究对象,结合办刊特色及发展实践,探讨建设高水平期刊的策略与举措。【结果】 NSR在重要研究成果组约和发表、访谈和论坛举办、学术质量控制、学术影响提升等方面开展了大量卓有成效的工作,有效地提高了期刊的品牌声誉,较好地服务了学术传播与交流。【结论】 NSR初步实现了全方位、多角度反映中外自然科学研究重要成就的定位和目标,学术指标和影响力得到快速提升,其办刊实践可为我国科技期刊的高质量发展提供参考与借鉴。     

The History and Future of the “ISPOR Value Flower”: Addressing Limitations of Conventional Cost-Effectiveness Analysis

ObjectivesSince its publication as part of the 2018 ISPOR Special Task Force (STF) on US Value Assessments, the “ISPOR value flower,” with its petals highlighting elements that may be overlooked or underappreciated in conventional drug value assessments, has been discussed and debated. We review the history of the value flower, describe recent developments, and consider implications for future value assessments.MethodsWe discuss various antecedents to the value flower, as well as conceptual and empirical articles published in the past 4 years.ResultsSince the publication of the ISPOR STF report, researchers have provided more rigorous theoretical and mathematical foundations for certain novel value elements (eg, severity of illness, value of insurance, value of hope) through “generalized risk-adjusted cost-effectiveness analysis,” which incorporates risk aversion in people’s preferences and uncertainty in treatment outcomes. Empirical estimates are also emerging to support key elements, such as insurance value, real option value, value of hope, and value of knowing. Although health technology assessment bodies have applied or are considering certain elements (eg, severity modifiers to cost-effectiveness thresholds), other elements have yet to gain traction.ConclusionsFive years after the STF began its work, the development of novel value measures continues to evolve. Although it is encouraging to see supporting empirical studies emerging, more are needed. Additional efforts are also needed to illustrate how the estimates can be used in the deliberative processes that are integral to health technology assessments.     

Toward Better Data Dashboards for US Drug Value Assessments

ObjectivesTo explore the use of data dashboards to convey information about a drug’s value, and reduce the need to collapse dimensions of value to a single measure.MethodsReview of the literature on US Drug Value Assessment Frameworks, and discussion of the value of data dashboards to improve the manner in which information on value is displayed.ResultsThe incremental cost per quality-adjusted life-year ratio is a useful starting point for conversation about a drug’s value, but it cannot reflect all of the elements of value about which different audiences care deeply. Data dashboards for drug value assessments can draw from other contexts. Decision makers should be presented with well-designed value dashboards containing various metrics, including conventional cost per quality-adjusted life-year ratios as well as measures of a drug’s impact on clinical and patient-centric outcomes, and on budgetary and distributional consequences, to convey a drug’s value along different dimensions.ConclusionsThe advent of US drug value frameworks in health care has forced a concomitant effort to develop appropriate information displays. Researchers should formally test different formats and elements.     

慢性病护理质量评价指标体系研究现状及启示

对国内外慢性病护理质量评价指标体系构建的理论框架、方法以及构建范围进行归纳总结,认为我国慢性病护理质量评价指标体系中应加强对患者结局指标的关注,应注意指标体系构建方法的科学性,还应积极探索多病种慢性病护理质量评价指标体系,构建统一的适合我国国情的慢性病护理质量评价指标体系。     

价值流应用于我国公立医院流程优化的文献分析

目的分析价值流在我国公立医院流程优化方面的应用情况,为医院管理者提供参考。方法以“价值流”“Value Stream Mapping”为检索词,搜索中国知网、万方数据库、维普中文期刊全文数据库以及PubMed数据库,收集2010年1月-2021年3月价值流应用于我国公立医院流程优化的相关文献,按照纳入排除标准确定文献后进行文献计量学分析。结果共纳入13篇文献。纳入文献发表时间主要为2015年-2020年,主要地区为广东省。涉及科室有儿科、放射科、手术室、妇科、出入院办理中心、神经科、门诊和检验科,涉及优化绩效指标共6项,涉及辅助工具使用的研究共10项,涉及政策策略可归纳为9种。结论通过价值流能实现流程优化。高层管理者参与对价值流优化有着关键作用。多工具配合使用能够提高价值流改善效率。未来应更多关注医务人员满意度与成本控制。     

大综述的组稿策略及其影响力分析

【目的】 探索大综述的组稿策略并分析其学术影响力,为科技期刊的创新发展提供经验和借鉴。【方法】 结合Science China Chemistry的办刊实践,梳理了大综述的组稿流程,包括选题的确定、特约编辑和作者的选择、编辑在撰稿和出版过程的重要角色,以及宣传推广措施,并分析大综述产生的影响。【结果】 大综述的学术引领性以及编辑部的多渠道宣传使其受到广泛关注并获得较高的下载量和被引频次。【结论】 组织和出版大综述是提升期刊学术质量和国际影响力的重要措施之一,值得同行们借鉴。     

喉副神经节瘤：1例报道及文献复习

目的 :提高临床诊治喉副神经节病的水平。方法 :总结喉副神经节病 1例诊治的全过程 ,并对文献进行复习。结果 :经右颈侧进路 ,从右梨状窝外侧壁切开暴露下咽腔 ,见右侧杓会厌皱裂隆起 ,黏膜下切除肿瘤约 3 0cm× 3 0cm ,术后 6年肿瘤复发。结论 :喉副神经节瘤的治愈依赖于对本病的认识 ,早期诊断和对肿瘤完整地切除     

Pediatric Femoral Shaft Fracture: An Age-Based Treatment Algorithm

PurposeFractures of the femoral shaft in children are common. The rates of bone growth and remodeling in children vary according to their ages, which affect their respective management. MethodsThis paper evaluates the incidence and patterns of pediatric femoral shaft fracture and the current concepts of treatments available.ResultsThe type of fracture—closed or open; stable or unstable—needs to be taken into account. Child abuse should be suspected in fractures sustained by infants. For younger children, non-surgical management is preferred, which include Pavlik harness (< 6 months old) and early spica casting (6 months to 6 years old). Older children (> 6 years old) usually benefit from surgical treatments as outcomes of non-surgical alternatives are worse and are associated with prolonged recovery times. These operative measures for older children that are 6–12 years old include elastic stable intramedullary nailing and submuscular plating. Factors to be considered when devising an appropriate intervention include body mass, location of injury, and nature of fracture. For adolescent and skeletally mature teenagers (> 12 years old), rigid antegrade entry intramedullary fixation is indicated. In the event of open fractures or polytrauma, external fixation should be considered as a temporary treatment method for initial fracture stabilization.ConclusionAn age-based and evidence-based algorithm has been proposed to guide surgeons in the process of evaluating an appropriate treatment.